These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9821453)

  • 1. Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels.
    Vestergaard P; Licht RW; Brodersen A; Rasmussen NA; Christensen H; Arngrim T; Grønvall B; Kristensen E; Poulstrup I
    Acta Psychiatr Scand; 1998 Oct; 98(4):310-5. PubMed ID: 9821453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lithium levels and therapeutic outcome in the prophylaxis of affective disorders: a retrospective study.
    Sashidharan SP; McGuire RJ; Glen AI
    Br J Psychiatry; 1982 Jun; 140():619-22. PubMed ID: 7104552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.
    Simhandl C; König B; Amann BL
    J Clin Psychiatry; 2014 Mar; 75(3):254-62; quiz 263. PubMed ID: 24717379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R; Lafuma A; Watkins S
    Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of relapses in subjects with mood disorder on lithium treatment.
    Gasperini M; Scherillo P; Manfredonia MG; Franchini L; Smeraldi E
    Eur Neuropsychopharmacol; 1993 Jun; 3(2):103-10. PubMed ID: 8364346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lithium levels and psychosocial function in patients with bipolar I disorder.
    Solomon DA; Ristow WR; Keller MB; Kane JM; Gelenberg AJ; Rosenbaum JF; Warshaw MG
    Am J Psychiatry; 1996 Oct; 153(10):1301-7. PubMed ID: 8831438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection.
    Grof P; Alda M; Grof E; Fox D; Cameron P
    Br J Psychiatry Suppl; 1993 Sep; (21):16-9. PubMed ID: 8217062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
    Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
    Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy of affective disorders: monotherapy or polypharmacy?
    König W; Rissom R; Kalfoglu G; Stein A; Reimer F
    Pharmacopsychiatry; 1988 Nov; 21(6):272-3. PubMed ID: 3244749
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders.
    Wood K; Swade C; Abou-Saleh M; Milln P; Coppen A
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):365S-368S. PubMed ID: 6407498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a loss of efficacy of lithium in patients treated for over 20 years?
    Berghöfer A; Müller-Oerlinghausen B
    Neuropsychobiology; 2000; 42 Suppl 1():46-9. PubMed ID: 11093072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data.
    Perlis RH; Sachs GS; Lafer B; Otto MW; Faraone SV; Kane JM; Rosenbaum JF
    Am J Psychiatry; 2002 Jul; 159(7):1155-9. PubMed ID: 12091193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study.
    Maj M; Starace F; Nolfe G; Kemali D
    Pharmacopsychiatry; 1986 Nov; 19(6):420-3. PubMed ID: 3797469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic.
    Maj M; Pirozzi R; Magliano L; Bartoli L
    Am J Psychiatry; 1998 Jan; 155(1):30-5. PubMed ID: 9433335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term lithium treatment. Some clinical, psychological and biological aspects.
    Smigan L
    Acta Psychiatr Scand; 1985 Feb; 71(2):160-70. PubMed ID: 3919528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder.
    Baethge C; Gruschka P; Smolka MN; Berghöfer A; Bschor T; Müller-Oerlinghausen B; Bauer M
    J Psychiatry Neurosci; 2003 Sep; 28(5):355-61. PubMed ID: 14517579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of lithium in the prophylaxis of affective disorders].
    Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
    Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.